30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Strategic Initiatives

Amedica to Divest Spine Business to CTL Medical -

CTL Medical will acquire the commercial spine business of Amedica for US $10.0MM. The transaction is slated to close within 3Q18. For 2017, AMDA posted product revenue of 11.2MM, -26% vs. 2016. CTL will exclusively own the portfolio of AMDA's metal and silicon nitride (SiNi) spine devices, and will have access to future SiNi spine products. CTL gains the entire existing inventory of Taurus, Preference and Valeo products, along with global regulatory clearances and IP. Manufacturing, R&D and all IP related to SiNi's core biomaterial technology will remain with AMDA, which will be CTL’s exclusive provider of SiNi products. (Amedica Corporation, 9/6/18)